Search
Thank you for powering UT Health San Antonio! You play an important role in fulfilling the promise we hold to make tomorrow a brighter, healthier day. Your partnership is what fuels our journey in advancing our missions and making a positive and significant difference in the communities we serve. All of us, working together, […]
Three decades after discoveries linking mutations in the BRCA1 gene to breast and ovarian cancer susceptibility, research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has pinpointed the molecular mechanism by which a large portion of these mutations cause cancers in women. The […]
Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO, Oct. 6, 2023 – Three decades after discoveries linking mutations in the BRCA1 gene to breast and ovarian cancer susceptibility, research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has pinpointed the molecular mechanism by […]
Sixteen faculty and staff leaders from across the institution recently completed the nine-month Leadership Excellence for Academic Professionals program. LEAP graduation on Sept. 22 was marked by the eight-member teams’ presentations to a panel of senior leaders. In those, the graduates summarized findings from projects in which they expanded their leadership knowledge and practical skills […]
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) announces the successful launch of Pluvicto, a radiopharmaceutical used to treat patients with advanced metastatic prostate cancer. Approved by the U.S. Food and Drug Administration in March of 2022, Pluvicto is a novel targeted molecular therapy that delivers radiation treatment […]
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO, Oct. 6, 2023 – The University of Texas Health Science Center at San Antonio (UT Health San Antonio) announces the successful launch of Pluvicto, a radiopharmaceutical used to treat patients with advanced metastatic prostate cancer. Approved by the U.S. Food and Drug Administration in March of 2022, Pluvicto […]
Weixing Zhao, PhD, and Sandeep Burma, PhD, both with the Department of Biochemistry and Structural Biology and the UT Health San Antonio Mays Cancer Center, were quoted in this article. Read More
Jennifer Sharpe Potter, PhD, MPH, vice president for research, professor of Psychiatry and Behavioral Sciences, and executive director, Be Well Texas, a statewide substance use treatment and recovery initiative of UT Health San Antonio, was quoted in this story. Read More (subscription required)
Laura Vasquez, PhD, Department of Health Sciences, was quoted in this story. Read More
The Spine Center at UT Health San Antonio is now open. The comprehensive, multidisciplinary center offers complete spine care for adults and children from a team of neurosurgeons, orthopaedic surgeons and specialists in non-operative care for all spine issues. It is located on the fourth floor of the Medical Arts and Research Center and houses the region’s only EOSedge, an imaging system…